Safety and Efficacy of Live Measles Vaccine Administered to a Crohn's Disease Patient Receiving Vedolizumab

Am J Gastroenterol. 2016 Apr;111(4):577. doi: 10.1038/ajg.2016.21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Crohn Disease / drug therapy*
  • Female
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Measles / prevention & control*
  • Measles-Mumps-Rubella Vaccine / therapeutic use*

Substances

  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • Measles-Mumps-Rubella Vaccine
  • vedolizumab